22 January 2018 / Zürich, Switzerland


The event agenda's time zone is CET.

Please indicate your availability for the one-to-one meetings during registration.

22 Jan 2018
08:00 – 09:00
Registration / Parallel one-to-one meetings
09:00 – 09:10
Welcome & Introduction
  • Danielle Spichiger, Director Cluster Life Sciences, Business & Economic Development, Canton of Zurich; President Life Science Zurich Business Network
  • Prof. Christoph Hock, Vice President Medicine, University of Zurich (UZH)
09:10 – 09:40
Novel Technologies Create New Molecules for Accessing Cutting-Edge Therapeutic Concepts

Prof. Andreas Plückthun, Professor of Biochemistry, UZH; Co-founder of Morphosys, Molecular Partners, G7/Heptares-Zurich

09:40 – 10:10
Lost in Medical Translation?

Prof. Ralph Müller, Professor and Head Laboratory for Bone Biomechanics, ETH Zurich; Co-founder b-cube AG / Pearltec AG

10:10 – 10:30
Coffee break
10:30 – 12:00
  • Prof. Bernd Bodenmiller, UZH
  • PD Dr. Irene Burger, USZ
  • Prof. Manfred Claassen, ETH Zurich
  • Dr. Christopher Millan, CTO & Co-founder CellSpring
  • Prof. Anne Müller, UZH
  • Dr. Christian Rommel, Global Head of Oncology Discovery, Roche
Parallel sessions morning
10:30 – 12:00
Immunology & Infection
  • Prof. Burkhard Becher, UZH
  • Dr. Mattias Ivarsson, CEO & Founder Inositec
  • Prof. Roland Martin, UZH & Wyss Zurich
  • Dr. Roch Ogier, Therapy Development Accelerator UZH
  • NEW: Jean-Philippe Tripet, Founder & Chairman ARAVIS
  • Prof. Alexandra Trkola, UZH

Parallel sessions morning
10:30 – 12:00
  • Prof. Frédéric Allain, ETH Zurich
  • PD Dr. Patrick Freund, UZH
  • Dr. Jan Grimm, CSO Neurimmune
  • Prof. Sebastian Jessberger, UZH
  • Prof. Lawrence Rajendran, UZH
  • Prof. Martin Schwab / Dr. Roman Willi, NovaGo

Parallel sessions morning
12:00 – 13:30
13:30 – 15:00
  • Dr. Chad Brokopp, CEO MabImmune
  • PD Dr. Stefano Ferrari, UZH
  • Dr. Christian Leisner, CEO CDR Life
  • PD Dr. Raffaella Santoro, UZH
  • Dr. Anne Schmidt, CEO Elthera
  • Prof. Simone Schürle, ETH Zurich
Parallel sessions afternoon
13:30 – 15:00
Immunology & Infection
  • Prof. Onur Boyman, USZ
  • Dr. Louise Jopling, Senior Director Immunology Scientific Innovation, Johnson & Johnson Innovation
  • Dr. Jan Kisielow, ETH Zurich
  • Prof. Andreas Lutterotti, UZH & Wyss Zurich
  • NEW: Jean-Philippe Tripet, Swiss Entrepreneurs Fund
  • Dr. Tomas de Wouters, CEO PharmaBiome

    Parallel sessions afternoon
    13:30 – 15:00
    • Prof. Sven Hirsch, ZHAW Life Sciences and Facility Management
    • Dr. Sanjay Keswani, Global Head of Neuroscience, Ophthalmology & Rare Diseases, Roche 
    • Prof. Isabelle Mansuy, UZH
    • Prof. Boris Quednow, UZH
    • Prof. Markus Rudin, ETH Zurich
    • Dr. Bechara Saab, CEO & Chief Scientist Mobio Interactive

    Parallel sessions afternoon
    15:00 – 15:30
    Coffee break
    15:30 – 16:00
    Hackers, Hipsters, Hustlers: Bio-Entrepreneurs in Zurich

    Prof. Roger Nitsch, Professor and Director Institute for Regenerative Medicine, UZH; Founder and President of the Board, Neurimmune

    16:00 – 16:30
    Cognitive Computing in Life Sciences

    Dr. Costas Bekas, Manager of Foundations of Cognitive Computing Group, IBM Research-Zurich

    16:30 – 17:15
    Panel Discussion «Apple, IBM, Google and Co: the Next Big Pharma?»
    • Dr. Costas Bekas, Manager of Foundations of Cognitive Computing Group, IBM Research-Zurich
    • Nathan Hubbard, Director of Digital and PHC Partnering, Roche Partnering
    • Dr. Denis Schapiro, winner of the first "UZH BioEntrepreneur-Fellowship" 2017
    • Prof. Effy Vayena, Professor of Bioethics and Health Policy, ETH Zurich

    moderated by Barnaby Skinner, Data Journalist, Tamedia

    17:15 – 17:30
    Summary, Outlook and Closing Remarks

    Prof. Ernst Hafen, Institute of Molecular Systems Biology, ETH Zürich, President of BIO-TECHNOPARK Schlieren-Zurich and MIDATA Genossenschaft 

    Prof. Detlef Günther, Vice President Research and Corporate Relations, ETH Zurich

    17:30 – 18:30
    The event agenda's time zone is CET.